Prevalence of sarcopenia in older women and level of agreement between the diagnostic instruments proposed by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)

被引:3
|
作者
Sutil, Daiana Vieira [1 ]
Parentoni, Adriana Netto [2 ]
Teixeira, Leonardo Augusto Da Costa [2 ]
Moreira, Bruno de Souza [3 ]
Leopoldino, Amanda Aparecida Oliveira [4 ]
Mendonca, Vanessa Amaral [2 ]
Lacerda, Ana Cristina Rodrigues [2 ]
Danielewicz, Ana Lucia [5 ]
de Avelar, Nubia Carelli Pereira [5 ]
机构
[1] Univ Fed Santa Catarina, Univ Fed Santa Catarina, Ararangua, SC, Brazil
[2] Fed Univ Jequitinhonha & Mucuri Valleys, Univ Fed Vales Jequitinhonha & Mucuri, Diamantina, MG, Brazil
[3] Fed Univ Minas Gerais & Oswaldo Cruz Fdn Minas Ger, Univ Fed Minas Gerais & Fundacao Oswaldo Cruz Mina, Ctr Studies Publ Hlth & Aging, Nucleo Estudos Saude Publ & Envelhecimento, Belo Horizonte, MG, Brazil
[4] Fac Med Sci Minas Gerais, Fac Ciencias Med Minas Gerais, Belo Horizonte, MG, Brazil
[5] Univ Fed Santa Catarina, Univ Fed Santa Catarina, Dept Hlth Sci, 3201 Jardim Ave Ararangua, BR-88906072 Ararangua, SC, Brazil
关键词
Sarcopenia; Aged; Prevalence; Diagnosis; EWGSOP2; GENDER-DIFFERENCES; PERFORMANCE; DISABILITY; STRENGTH;
D O I
10.1186/s12891-023-06287-z
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundThe European Working Group on Sarcopenia in Older People 2 (EWGSOP2) proposed the use of different diagnostic tools to assess sarcopenia. This study aimed to determine prevalence rates of sarcopenia according to the diagnostic instruments proposed by EWGSOP2 and to assess their level of agreement in older Brazilian women.MethodsA cross-sectional study with 161 community-dwelling older Brazilian women. Probable sarcopenia was assessed through Handgrip Strength (HGS) and the 5-times sit-to-stand test (5XSST). In addition to reduced strength, Appendicular Skeletal Muscle Mass (ASM) (obtained by Dual-energy X-ray absorptiometry) and ASM/height(2) were considered for diagnosis confirmation. Sarcopenia severity was determined by reduced muscle strength and mass and poor functional performance assessed by Gait Speed (GS), Short Physical Performance Battery (SPPB), and Timed Up and Go test (TUG). McNemar's test and Cochran's Q-test were used to compare sarcopenia prevalence. Cohen's Kappa and Fleiss's Kappa tests were used to assess the level of agreement.ResultsThe prevalence of probable sarcopenia was significantly different (p < 0.05) when using HGS (12.8%) and 5XSST (40.6%). Regarding confirmed sarcopenia, the prevalence was lower when using ASM/height(2) than with ASM. Regarding severity, the use of SPPB resulted in a higher prevalence in relation to GS and TUG.ConclusionThere were differences in the prevalence rates of sarcopenia and low agreement between the diagnostic instruments proposed by the EWGSOP2. The findings suggest that these issues must be considered in the discussion on the concept and assessment of sarcopenia, which could ultimately help to better identify patients with this disease in different populations.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prevalence of sarcopenia in older women and level of agreement between the diagnostic instruments proposed by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2)
    Daiana Vieira Sutil
    Adriana Netto Parentoni
    Leonardo Augusto Da Costa Teixeira
    Bruno de Souza Moreira
    Amanda Aparecida Oliveira Leopoldino
    Vanessa Amaral Mendonça
    Ana Cristina Rodrigues Lacerda
    Ana Lúcia Danielewicz
    Núbia Carelli Pereira de Avelar
    [J]. BMC Musculoskeletal Disorders, 24
  • [2] Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria
    Chew, J.
    Yeo, A.
    Yew, S.
    Lim, J. P.
    Tay, L.
    Ding, Y. Y.
    Lim, W. S.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2020, 24 (06): : 614 - 618
  • [3] Muscle Strength Definitions Matter: Prevalence of Sarcopenia and Predictive Validity for Adverse Outcomes Using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) Criteria
    Justin Chew
    A. Yeo
    S. Yew
    J. P. Lim
    L. Tay
    Y. Y. Ding
    W. S. Lim
    [J]. The journal of nutrition, health & aging, 2020, 24 : 614 - 618
  • [4] European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?
    Bernardes Spexoto, Maria Claudia
    Ramirez, Paula Camila
    Maximo, Roberta de Oliveira
    Steptoe, Andrew
    de Oliveira, Cesar
    Alexandre, Tiago da Silva
    [J]. AGE AND AGEING, 2022, 51 (07)
  • [5] Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria
    Francesca Remelli
    Elisa Maietti
    Pasquale Abete
    Giuseppe Bellelli
    Mario Bo
    Antonio Cherubini
    Francesco Corica
    Mauro Di Bari
    Marcello Maggio
    Maria Rosaria Rizzo
    Andrea P. Rossi
    Francesco Landi
    Stefano Volpato
    [J]. Aging Clinical and Experimental Research, 2022, 34 : 113 - 120
  • [6] Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults
    Ola Wallengren
    Ingvar Bosaeus
    Kerstin Frändin
    Lauren Lissner
    Hanna Falk Erhag
    Hanna Wetterberg
    Therese Rydberg Sterner
    Lina Rydén
    Elisabet Rothenberg
    Ingmar Skoog
    [J]. BMC Geriatrics, 21
  • [7] Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults
    Wallengren, Ola
    Bosaeus, Ingvar
    Frandin, Kerstin
    Lissner, Lauren
    Erhag, Hanna Falk
    Wetterberg, Hanna
    Sterner, Therese Rydberg
    Ryden, Lina
    Rothenberg, Elisabet
    Skoog, Ingmar
    [J]. BMC GERIATRICS, 2021, 21 (01)
  • [8] Recent consensus on definition and diagnosis for sarcopenia (EWGSOP2): agreement with the first consensus (EWGSOP1) and with tools for screening sarcopenia in older women
    Fernandes L.V.
    de Oliveira E.P.
    Castro I.C.
    de Melo C.M.
    Limirio L.S.
    Veiga E.P.
    Porto L.C.J.
    Santiago A.F.
    [J]. Nutrire, 46 (2)
  • [9] Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria
    Remelli, Francesca
    Maietti, Elisa
    Abete, Pasquale
    Bellelli, Giuseppe
    Bo, Mario
    Cherubini, Antonio
    Corica, Francesco
    Di Bari, Mauro
    Maggio, Marcello
    Rizzo, Maria Rosaria
    Rossi, Andrea P.
    Landi, Francesco
    Volpato, Stefano
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (01) : 113 - 120
  • [10] Agreement Between Initial and Revised European Working Group on Sarcopenia in Older People Definitions
    Phu, Steven
    Vogrin, Sara
    Zanker, Jesse
    Hassan, Ebrahim Bani
    Al Saedi, Ahmed
    Duque, Gustavo
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (03) : 382 - +